Latest stories on FHTX
Foghorn Therapeutics GAAP EPS of -$0.10 beats by $0.14, revenue of $16.1M beats by $8.17M
Seeking Alpha68 · bullishearnings
Foghorn Therapeutics Inc. (FHTX) files 8-K
SEC 8-K50 · neutralgeneral
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
Business Insider55 · neutralgeneral
Foghorn Therapeutics Inc. (FHTX) files 8-K
SEC 8-K50 · neutralgeneral
Foghorn Therapeutics Inc. (FHTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral